FDA uses regulatory science to assess biological products

02/19/2014 | FDA Voice blog

The FDA uses regulatory science to transform innovative medical research into life-enhancing or life-saving biological products, writes Carolyn A. Wilson of the FDA Center for Biologics Evaluation and Research. The agency also conducts research, and these studies help public health officials and FDA regulators identify possible adverse events that are actually tied to the use of a specific product, she writes.

View Full Article in:

FDA Voice blog

Published in Brief: